Nicola Collar

Title: Nicola Collar: Innovator in Central Nervous System Treatments

Introduction

Nicola Collar is a prominent inventor based in Hoboken, NJ (US), known for her significant contributions to the field of pharmaceuticals. With a total of six patents to her name, she has focused her research on developing innovative treatments for various central nervous system disorders.

Latest Patents

Among her latest patents, one invention relates to heterocyclic substituted carbonyl derivatives that exhibit selective binding to dopamine D receptors. This invention provides a method for treating central nervous system disorders associated with dopamine D receptor activity. The disorders that may be treated include psychotic disorders, substance dependence, dyskinetic disorders such as Parkinson's Disease, dementia, anxiety disorders, sleep disorders, circadian rhythm disorders, and mood disorders. Additionally, the invention encompasses processes for preparing these compounds and their use as imaging agents for dopamine D receptors. Another patent involves substituted thienopyrrole carboxylic acid amides and pyrrolothiazole carboxylic acid amides, which serve as inhibitors of casein kinase I. This invention also addresses the treatment of mood and sleep disorders through the administration of specific compounds.

Career Highlights

Nicola Collar has made remarkable strides in her career, particularly through her work at Aventis Pharmaceuticals Inc. Her research has led to advancements in the understanding and treatment of complex neurological conditions.

Collaborations

Throughout her career, Nicola has collaborated with notable colleagues, including David Fink and Yulin Chiang, who have contributed to her research endeavors.

Conclusion

Nicola Collar's innovative work in the pharmaceutical industry has paved the way for new treatments for central nervous system disorders. Her patents reflect her commitment to improving patient outcomes through scientific advancements.